Skybiotech Healthcare (BOM:512036) GF Score: 23/100 (As of Aug. 14, 2026) — 36% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:512036 Skybiotech Healthcare Ltd BOM:512036
23 GF Score
Price ₹148.95
! 4 Warning Signs
View Full Analysis

What is Skybiotech Healthcare GF Score?

Skybiotech Healthcare BOM:512036 -0.30% 23 GF Score is 23 as of Aug. 14, 2026, which is 36% below its 10-year median of 36.00. GuruFocus rates BOM:512036 with a GF Score™ of 23/100. The stock has 4 warning signs investors should review.

Skybiotech Healthcare has the GF Score of 23, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 2/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 2/10
5. Momentum Rank : 9/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Skybiotech Healthcare might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Skybiotech Healthcare  (BOM:512036) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Skybiotech Healthcare GF Score Related Terms

BOM:512036 vs MMM, HON: GF Score Comparison

For the Conglomerates subindustry, Skybiotech Healthcare's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Skybiotech Healthcare GF Score vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, Skybiotech Healthcare's GF Score distribution charts can be found below:

* The bar in red indicates where Skybiotech Healthcare's GF Score falls into.


BOM:512036
23GF Score
Skybiotech Healthcare Ltd BOM:512036
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 23 mean?
Skybiotech Healthcare (BOM:512036) has a GF Score of 23 as of Aug. 14, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Skybiotech Healthcare and its competitors. This is 36% below median its historical median of 36.00. Over the past decade, Skybiotech Healthcare's GF Score has ranged from 5.00 to 64.00.
Is Skybiotech Healthcare's GF Score too high?
Skybiotech Healthcare's current GF Score of 23 is 36% below median its 10-year median of 36.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 64.00. Overall, Skybiotech Healthcare has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Skybiotech Healthcare's GF Score compare to MMM and HON?
Skybiotech Healthcare's GF Score of 23 can be compared against companies in the Conglomerates industry. Historically, Skybiotech Healthcare's own GF Score has ranged from 5.00 to 64.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Conglomerates company?
A good GF Score depends on the Conglomerates industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Skybiotech Healthcare and its competitors. Skybiotech Healthcare's current GF Score is 23, which is 36% below median its own 10-year median of 36.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skybiotech Healthcare stock overvalued right now?
Skybiotech Healthcare (BOM:512036) has a current GF Score of 23. The current GF Score is 23, which is 36% below median its 10-year median of 36.00. Skybiotech Healthcare's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Skybiotech Healthcare (BOM:512036), the current GF Score is 23 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Skybiotech Healthcare Business Description

Address Paithan Road, Gevrai Tanda, Gut No. 05, Chhatrapati Sambhaji Nagar, MH, IND, 431002
Skybiotech Healthcare Ltd, formerly Kapil Cotex Ltd is engaged in textiles and allied products, including dyeing, printing, spinning, weaving, and manufacturing fabrics from raw cotton. During the year under review, the company has not generated any revenue from its core business activities. Instead, it earned income from consultancy services for foreign clients and from investments in shares, generating capital gains and dividends. The company's current revenue mainly comes from these non-core activities rather than textile manufacturing.
23GF Score

Get the complete analysis for BOM:512036

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹148.95
Price